Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07462143 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Phase Ⅱ/Ⅲ Clinical Trial of RC148 Plus Chemotherapy as 1L Therapy for Unresectable or Metastatic Colorectal Cancer

StatusRecruiting
PhasePhase 2/3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Enrollment reduced: 700 → 80 participants Recruitment opened · Primary completion moved earlier from Dec 31, 2027 to May 12, 2027 · Study sites revised (19)v3 Show 3 more changesShow less
    • Recruitment opened
    • Primary completion moved earlier from Dec 31, 2027 to May 12, 2027
    • Study sites revised (19)

    See this version in full on ClinicalTrials.gov ↗

  2. Trial status: Not Yet Recruiting to Recruiting Enrollment target: 700 to 80 · Primary completion date: Dec 31, 2027 to May 12, 2027 · Start date changed from estimate of Apr 30, 2026 to May 12, 2026 · 1 morev2 Show 4 more changesShow less
    • Enrollment target: 700 to 80
    • Primary completion date: Dec 31, 2027 to May 12, 2027
    • Start date changed from estimate of Apr 30, 2026 to May 12, 2026
    • Site details revised at 19 of 19 sites
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a Phase Ⅱ/Ⅲ study. The purpose of this study is to evaluate the efficacy and safety of RC148 combined with chemotherapy for the first-line treatment of unresectable metastatic colorectal cancer (CRC)
Trial Details
NCT Number NCT07462143
Lead Sponsor RemeGen Co., Ltd.
Conditions Colorectal (Colon or Rectal) Cancer
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov